XY018 is an orally available, selective and highly effective ROR-gamma antagonist with antitumor activity, inhibits ROR-gamma activity, inhibits tumor cell growth, and can be used to study drug-resistant prostate cancer.
Molecular Weight:
516.37
CAS Number:
[1873358-87-2]
Formula:
C23H15F7N2O4
Target:
ROR
T24213
T24213
* VAT and and shipping costs not included. Errors and price changes excepted